CLINICAL_TRIALS
trial_result
· 2016-01-07
Clinical Trial Update: The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) [Phase 3]
Summary
The EVOLVE II Phase 3 trial evaluating the SYNERGY Stent System for treatment of atherosclerotic lesions in coronary arteries has completed, with results posted…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-01-07